title: Efficacy of tamsulosin in medical expulsive therapy for distal ureteral calculi.
abstract: OBJECTIVE
  To evaluate the potential role of tamsulosin in the medical treatment of distal ureteral stones.
  
  
  METHODS
  Ninety patients with symptomatic distal ureteral calculi were enrolled. They were randomly divided into two groups: Group A (n=45) received diclofenac 100 mg on demand for 4 weeks plus levofloxacin 250 mg daily for the first week and were well hydrated; and Group B (n=45) received the same therapy plus tamsulosin 0.4 mg/daily for 4 weeks. Abdominal ultrasound scans and KUB X-rays were performed weekly. Stone expulsion rates, time to expulsion, pain episodes and analgesic usage were determined. Intervention by means of shock-wave lithotripsy (SWL) or ureteroscopy was evaluated.
  
  
  RESULTS
  The stone expulsion rate was 51.1% for Group A, compared to 88.9% for Group B (p=0.001). The average time to expulsion was 12.53+/-2.12 days for Group A and 7.32+/-0.78 days for Group B (p=0.04). The number of pain episodes was significantly lower in Group B and mean use of analgesics was lower for Group B (0.14+/-0.5 vials) than Group A (2.78+/-2.7 vials). Twenty-two patients in Group A failed to pass their stones after 4 weeks but only five in Group B. Of the patients who were not stone-free, 19 were treated with SWL and eight underwent ureteroscopy.
  
  
  CONCLUSIONS
  Our study reveals the efficacy of tamsulosin for the treatment of distal ureteral stones. Tamsulosin should be added to the standard medical approach for treating these stones.
authors.affiliation: Urology Department, Assiut University, Assiut, Egypt. sayedmohamed_22@hotmail.com
authors.forename: Mohamed Abdel-Basir
authors.initials: MA
authors.lastname: Sayed
authors.forename: Ahmad
authors.initials: A
authors.lastname: Abolyosr
authors.forename: Medhat Ahmad
authors.initials: MA
authors.lastname: Abdalla
authors.forename: Ahmad Shehata
authors.initials: AS
authors.lastname: El-Azab
mesh_terms: D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004008:Diclofenac / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D013449:Sulfonamides / Q000627:therapeutic use*; D000077409:Tamsulosin; D013997:Time Factors; D016896:Treatment Outcome; D014514:Ureteral Calculi / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000317:Adrenergic alpha-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013449:Sulfonamides; D004008:Diclofenac; D000077409:Tamsulosin